3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Gastrointestinal
1
Conditions
Pancreatic Cyst
1
Interventions
Oxaliplatin
154
Fluorouracil
138
Gemcitabine
119
Bevacizumab
115
Leucovorin
106
Specimen Handling
105
Capecitabine
96
pembrolizumab
90
Magnetic Resonance Spectroscopy
82
Nivolumab
80
Cisplatin
80
Irinotecan
72
durvalumab
63
Cetuximab
62
Paclitaxel
60
Biopsy
60
130-nm albumin-bound paclitaxel
58
Radiotherapy
49
atezolizumab
44
Albumin-Bound Paclitaxel
38
Taxes
36
Carboplatin
36
Folfox protocol
34
Drug Therapy
33
lenvatinib
29
dehydroftorafur
29
sintilimab
28
Cyclophosphamide
28
tislelizumab
27
Radiation
26
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ethanol
×
Gastrointestinal
×
90 days
×
Clear all
NCT03085004
2026-03-30
CHARM
Milton S. Hershey Medical Center
Phase 3
Terminated
75 enrolled